Daewoong Acquires Pet Drug and Telemedicine Service Company 'Daewoong Pet'

[Asia Economy Reporter Gong Byung-sun] Daewoong announced on the 19th that it will acquire Daewoong Pet, a company developing new drugs for companion animals, non-face-to-face medical services, and clinical trial support platforms.

Daewoong stated that it acquired the company to enter the companion animal pharmaceuticals and medical services sectors. Daewoong Pet's capital is 528 million KRW, with total assets and total liabilities of 523 million KRW and 56 million KRW, respectively.